USPTO serial 79372934
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kisuk Lee
Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Avenue, Suite 400Saint Louis, MO 63105United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagent paper for inspection other than for medical or veterinary purposes; china clay; by-products of the processing of cereals for industrial purposes; chemicals used in industry/science and photography as well as in agriculture/ horticulture and forestry; artificial sweeteners used in industry; chemicals and adhesives used in industry; cell growth media for growing cells for use in scientific research; cells for scientific or laboratory purposes; ceramic glazings in the nature of a dry chemical preparation for use in the manufacture of ceramics; unprocessed artificial resin; antifreezing liquids; birdlime; biological preparations for use in biotechnology industry other than medical; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; hydraulic oils; metalloids; stem cells, other than for medical or veterinary purposes; chemical compositions for the manufacture of technical ceramics; chemical paper pulp | ACTIVE | — |
| 005 | All purpose deodorizing preparations for household, commercial or industrial use; mothproof paper; insecticides; dietary supplements; first aid boxes sold filled; food for babies; preparations of microorganisms for medical and veterinary use; medicated baby diapers; medical and surgical plasters; cell culture media for medical use; biological tissue cultures for medical purposes; cells for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparationsfor the treatment of viral diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of dermatological diseases; pharmaceutical preparations for the treatment of cancer and tumor; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of endocrine diseases; pharmaceutical preparations for the treatment of genitourinary diseases; pharmaceutical preparations for the treatment of hepatological diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of cardiovascular disease; milk sugar for medical purposes [lactose]; diagnostic preparations for medical purposes; adhesive skin patches for medical use; antibodies for medical purposes; surgical implants grown from living tissue stem cells; dental abrasives; fly glue | ACTIVE | — |
| 042 | Research in relation to technology for construction purposes; architectural services; development of engineering products; scientific research; testing, inspection and research services in the fields of agriculture, livestock breeding and fisheries; development of biotechnology; drug discovery services; outsource service providers in the field of information technology relating to installation, maintenance and repair of computer software; pharmaceutical research and development; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; medical research laboratories; dress design services; analysis and evaluation of medical product development; new product design; design and development of computers and programs for computers; design, maintenance, rental and updating of computer software; development of computer hardware; marine, aerial and land surveying; cosmetic research; research in the field of environmental conservation and protection | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 3, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 18, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 18, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 29, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 13, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 13, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 13, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 19, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 29, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 29, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 10, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 9, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |